Kairos Pharma, LTD. Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Placement Agent Agreement, dated January 16, 2025, between Kairos Pharma, Ltd. and Boustead Securities LLC
Kairos Pharma, LTD.
2025
Form of Placement Agent Warrants
Kairos Pharma, LTD.
NY
2025
Form of Common Warrants
Kairos Pharma, LTD.
2025
Form of Lock-up Agreement
Kairos Pharma, LTD.
2025
Director Offer Letter, dated December 10, 2024, between Kairos Pharma, Ltd. and Rahul Singhvi
Kairos Pharma, LTD.
DE
2024
Second Conversion Agreement, dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center
Kairos Pharma, LTD.
CA
2024
Amendment to Laon Agreement, dated August 16, 2024, between the Company and Neil Bhowmick
Kairos Pharma, LTD.
2024
Conversion Agreement, dated March 7, 2024, between Cedars-Sinai Medical Center, Kairos Pharma, Ltd. and Enviro Therapeutics, Inc
Kairos Pharma, LTD.
CA
2024
Form of Director Offer Letter
Kairos Pharma, LTD.
DE
2023
Amendment to Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated January 9, 2021 (re Sensitization of Solid Tumors)
Kairos Pharma, LTD.
2023
Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated March 16, 2020 (re Sensitization of Solid Tumors)
Kairos Pharma, LTD.
CA
2023
Amendment to Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated January 11, 2021 (re Depletion of Mitochondrial DNA)
Kairos Pharma, LTD.
2023
Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated March 16, 2020 (re Depletion of Mitochondrial DNA)
Kairos Pharma, LTD.
CA
2023